Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort

By Masciari Serena  

Breast Cancer Research and Treatment, Vol. 133, Iss. 3, 2012-06 ,pp. : 1125-1130

Springer Publishing Company

Access to resources Recommend Favorite

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1 , BRCA2 , and TP53 gene mutations

By Manoukian Siranoush  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 207-215

Springer Publishing Company

Access to resources Recommend Favorite

TP53 genetic alterations in Arab breast cancer patients: Novel mutations, pattern and distribution

By                  

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 363-369

Spandidos Publications

Access to resources Recommend Favorite

Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations

By Hagen Anne   Bofin Anna   Ytterhus Borgny   Maehle Lovise   Kjellevold Kjell   Myhre Hans   Møller Pål   Lønning Per  

Acta Oncologica, Vol. 46, Iss. 2, 2007-01 ,pp. : 199-203

Informa Healthcare

Access to resources Recommend Favorite

A comparison among HER2, TP53, PAI-1, angiogenesis, and proliferation activity as prognostic variables in tumours from 408 patients diagnosed with early breast cancer

By Vrou Offersen Birgitte   Alsner Jan   Ege Olsen Karen   Riisbro Rikke   Brunner Nils   Brandt Sørensen Flemming   Sandahl Sørensen Boe   Olrik Schlemmer Birgitte   Overgaard Jens  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 618-632

Informa Healthcare

Access to resources Recommend Favorite